Therefore, serological identification of LGALS3BP, LAMB1-3, LAMC2, BMP1, AGRN, EGFR, COL7A, FBN1, and GPC1 may prove of great clinical value in identifying metastatic potential of BC prior to pathological and imaging evidence. Here, LGALS3BP is linked to breast cancer.